ArticleCancer immunology research2020
Self-Maintaining CD103
Open access · bronzeAbstract read
In one paragraph
Article in Cancer immunology research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.
- Association of CD103+ T cell infiltration with overall survival in solid tumors of the digestive tract and its potential in anti-PD-1 treatment: A review and meta-analysis.Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia · 2022Pooled it
- Unveiling structural determinants of peptide recognition by public and private SARS-CoV-2-specific T-cell receptors.Nature communications · 2026Article
- Transcriptomic analysis of tissue-resident memory T cells of the fallopian tube reveals a precursor immune surveillance network for ovarian cancer prevention.Nature communications · 2026Article
- CD8MedComm · 2026Review
- Identification of proliferating CD103Virchows Archiv : an international journal of pathology · 2026Article
- Spatiotemporal immune dynamics in lung cancer progression and treatment.Breathe (Sheffield, England) · 2026Review
- Expression of CD103 facilitates localization and activation of CD4Mucosal immunology · 2026Article
- Phenotypic Characterization and Prognostic Impact of CD103+ Tissue-Resident Memory T Cells in Diffuse Large B-cell Lymphoma.Cancer immunology research · 2026Article
- Novel common target genes for breast cancer and colorectal cancer: a Mendelian randomization and spatial transcriptomics study.Discover oncology · 2025Article
- Tissue-Resident Memory T Cells: Pioneering New Avenues in Cancer Immunotherapy.Cancer medicine · 2025Review
- Long-persisting SARS-CoV-2 spike-specific CD4Nature communications · 2025Article
- Inhibition of Glutamate-to-Glutathione Flux Promotes Tumor Antigen Presentation in Colorectal Cancer Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Ex vivo expansion and hydrogel-mediated in vivo delivery of tissue-resident memory T cells for immunotherapy.Science advances · 2024Article
- Optimizing the spatial immune landscape of CD103Cellular oncology (Dordrecht, Netherlands) · 2024Article
- Immune Checkpoints and Cellular Landscape of the Tumor Microenvironment in Non-Melanoma Skin Cancer (NMSC).Cells · 2024Review
- Resident memory T cells and cancer.Immunity · 2024Review
- Transient synaptic CD61 pairing with CD103 increases the cytotoxicity of antigen-specific T cells.Nature immunology · 2024Article
- Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity.Nature immunology · 2024Article
- EMT-induced immune evasion: connecting the dots from mechanisms to therapy.Clinical and experimental medicine · 2023Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 5 institutions in 2 countries.
Megat Abd HamidChinese Academy of Medical Sciences (CAMS) Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-9072-1367
Huw Colin-YorkMedical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
Nasullah Khalid-AlhamInstitute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-1479-3251
Molly BrowneNuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
Lucia CerundoloNuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.ORCID 0000-0003-0040-3793
Ji-Li ChenMedical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
Xuan YaoChinese Academy of Medical Sciences (CAMS) Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Samara Rosendo-MachadoMedical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
Craig WaughFlow Cytometry Facility, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
David Maldonado-PerezNuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
Emma BowesNuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
Clare VerrillOxford National Institute of Health Research (NIHR) Biomedical Research Centre, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.ORCID 0000-0002-4905-8233
Vincenzo CerundoloChinese Academy of Medical Sciences (CAMS) Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-0040-3793
Christopher P ConlonChinese Academy of Medical Sciences (CAMS) Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-3531-2464
Marco FritzscheMedical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
Yanchun Peng *Chinese Academy of Medical Sciences (CAMS) Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Tao Dong *Chinese Academy of Medical Sciences (CAMS) Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom. tao.dong@imm.ox.ac.uk.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNJohn Radcliffe Hospital · GBMRC Human Immunology Unit · GBCRUK/MRC Oxford Institute for Radiation Oncology · GBMRC Weatherall Institute of Molecular Medicine · GB
Funding
Cancer Research UK 11331Cancer Research UK 17722Medical Research Council G0501975Medical Research Council G0600520Medical Research Council G0800158Medical Research Council G1000800Medical Research Council G1001046Medical Research Council MC_PC_15002Medical Research Council MC_U137884181Medical Research Council MC_UU_00008/1Medical Research Council MC_UU_00008/11Medical Research Council MC_UU_12010/1Medical Research Council MR/K01577X/1Medical Research Council MR/K021222/1Medical Research Council MR/L018942/1Wellcome TrustWellcome Trust 212343/Z/18/Z
Abstract
Enrichment of CD103
Indexed as
Antigens, CDCD8-Positive T-LymphocytesHumansImmunophenotypingIntegrin alpha ChainsLung NeoplasmsLymphocytes, Tumor-InfiltratingNeoplasmsPrognosisReceptors, Antigen, T-CellT-Lymphocytes, CytotoxicTransforming Growth Factor beta1alpha E integrinsAntigens, CDIntegrin alpha ChainsReceptors, Antigen, T-CellTGFB1 protein, humanTransforming Growth Factor beta1
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.